Andrew Dreyfus

Director, Ironwood Pharmaceuticals.

Companies

Alto Neuroscience, Inc.Board member Feb 1, 2024 to now¹
Ironwood PharmaceuticalsBoard member Apr 7, 2016 to now²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Ironwood Pharmaceuticals IRWD228,313 shares³$860.7K at $3.77Jun 10, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 10, 2025Granted 45,000 shares of Ironwood Pharmaceuticals³
Jun 18, 2024Granted 24,311 shares of Ironwood Pharmaceuticals⁴
Jun 20, 2023Granted 22,350 shares of Ironwood Pharmaceuticals⁵
Jun 1, 2022Granted 21,571 shares of Ironwood Pharmaceuticals⁶
Dec 15, 2021Granted 1,431 shares of Ironwood Pharmaceuticals⁷

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAlto Neuroscience, Inc., Board member
2
SEC EDGARIronwood Pharmaceuticals, Board member
3
SEC EDGARIronwood Pharmaceuticals shares after the filing of Jun 10, 2025
4
SEC EDGARForm 4 filed Jun 21, 2024
5
SEC EDGARForm 4 filed Jun 22, 2023
6
SEC EDGARForm 4 filed Jun 3, 2022
7
SEC EDGARForm 4 filed Dec 17, 2021